JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Maines, M. D.
Right arrow Articles by Panahian, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Maines, M. D.
Right arrow Articles by Panahian, N.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*BROMOBENZENE

Vol. 296, Issue 3, 1091-1097, March 2001

Nuclear Localization of Biliverdin Reductase in the Rat Kidney: Response to Nephrotoxins That Induce Heme Oxygenase-1

Mahin D. Maines, James F. Ewing1, Tian J. Huang and Nariman Panahian

Department of Biochemistry and Biophysics, University of Rochester School of Medicine, Rochester, New York

Biliverdin reductase catalyzes the reduction of biliverdin, the product of heme oxygenase (HO) activity, to bilirubin. The reductase is unique among all enzymes characterized to date in being dual pH/cofactor-dependent. Until now the enzyme was assumed to be a noninducible cytosolic protein. This report, for the first time, demonstrates induction and nuclear localization of reductase in rat kidney in response to HO-1 inducers: bacterial lipopolysaccharide (LPS) and bromobenzene. The study also demonstrates that nuclear localization requires an intact nuclear localization signal and is responsive to cGMP. Specifically 16 h after treatment of rats (i.p.) with LPS (5 mg/kg), there was an increase in nuclear biliverdin reductase as determined by immunostaining, Western blotting, and activity analysis. Induction and nuclear localization of the reductase in kidney was also observed in bromobenzene-treated rats (2 mmol/kg, s.c., 24 h). The reductase message levels, however, were not increased in response to either treatment, suggesting post-transcriptional activation of the reductase by LPS and bromobenzene. The mechanism of nuclear transport of the reductase was examined using HeLa cells transfected with the hemagglutinin-tagged reductase construct. When cells were treated with 8-Br-cGMP the protein translocated into the nucleus. Mutation of the putative nuclear localization signal domain of the reductase blocked nuclear transport of the protein. We suggest the significance of nuclear localization of the reductase may relate to: 1) chain-breaking antioxidant activity of bilirubin; 2) inhibition of superoxide formation by bilirubin; and 3) modulation of the signal transduction pathways.


1 Current address: Arqule, Boston, MA.


0022-3565/01/2963-1091$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 2001 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Pharmacol. Rev.Home page
N. G. Abraham and A. Kappas
Pharmacological and Clinical Aspects of Heme Oxygenase
Pharmacol. Rev., March 1, 2008; 60(1): 79 - 127.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
R. Zeng, Y. Yao, M. Han, X. Zhao, X.-C. Liu, J. Wei, Y. Luo, J. Zhang, J. Zhou, S. Wang, et al.
Biliverdin Reductase Mediates Hypoxia-Induced EMT via PI3-Kinase and Akt
J. Am. Soc. Nephrol., February 1, 2008; 19(2): 380 - 387.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. D. Maines, T. Miralem, N. Lerner-Marmarosh, J. Shen, and P. E. M. Gibbs
Human Biliverdin Reductase, a Previously Unknown Activator of Protein Kinase C betaII
J. Biol. Chem., March 16, 2007; 282(11): 8110 - 8122.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
D. P. Converso, C. Taille, M. C. Carreras, A. Jaitovich, J. J. Poderoso, and J. Boczkowski
HO-1 is located in liver mitochondria and modulates mitochondrial heme content and metabolism
FASEB J, June 1, 2006; 20(8): 1236 - 1238.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
S. W. Ryter, J. Alam, and A. M. K. Choi
Heme Oxygenase-1/Carbon Monoxide: From Basic Science to Therapeutic Applications
Physiol Rev, April 1, 2006; 86(2): 583 - 650.
[Abstract] [Full Text] [PDF]


Home page
PhysiologyHome page
M. D. Maines
New Insights into Biliverdin Reductase Functions: Linking Heme Metabolism to Cell Signaling
Physiology, December 1, 2005; 20(6): 382 - 389.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
N. Lerner-Marmarosh, J. Shen, M. D. Torno, A. Kravets, Z. Hu, and M. D. Maines
Human biliverdin reductase: A member of the insulin receptor substrate family with serine/threonine/tyrosine kinase activity
PNAS, May 17, 2005; 102(20): 7109 - 7114.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Miralem, Z. Hu, M. D. Torno, K. M. Lelli, and M. D. Maines
Small Interference RNA-mediated Gene Silencing of Human Biliverdin Reductase, but Not That of Heme Oxygenase-1, Attenuates Arsenite-mediated Induction of the Oxygenase and Increases Apoptosis in 293A Kidney Cells
J. Biol. Chem., April 29, 2005; 280(17): 17084 - 17092.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Kravets, Z. Hu, T. Miralem, M. D. Torno, and M. D. Maines
Biliverdin Reductase, a Novel Regulator for Induction of Activating Transcription Factor-2 and Heme Oxygenase-1
J. Biol. Chem., May 7, 2004; 279(19): 19916 - 19923.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Z. Ahmad, M. Salim, and M. D. Maines
Human Biliverdin Reductase Is a Leucine Zipper-like DNA-binding Protein and Functions in Transcriptional Activation of Heme Oxygenase-1 by Oxidative Stress
J. Biol. Chem., March 8, 2002; 277(11): 9226 - 9232.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2001 by the American Society for Pharmacology and Experimental Therapeutics.